Adrienne L. Racanelli

Author

Wilmington University

Also Known As

A Racanelli, A. L. Racanelli, A.L. Racanelli, Adrienne L Racanelli, Adrienne L. Racanelli, Adrienne Racanelli

Publications

381

Citations

H-Index

Concepts

All Affiliations

Wilmington University DuPont (United States)Experimental Station

About

Adrienne L. Racanelli is an author at Wilmington University specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	315
2	Natural Sciences	2	2	87
3	Biochemistry	2	2	124
4	Engineering	1	1	47
5	Health Sciences	1	1	10

Adrienne L. Racanelli

Publications

351

Citations

H-Index

Page 1

	Year	Citations
Discovery of an Orally Active Series of Isoxazoline Glycoprotein IIb/IIIa Antagonists Chu‐Biao Xue, John Wityak, Thais M. Sielecki, Journal of Medicinal Chemistry Pharmaceutical ScienceOrally Active SeriesGlycobiologyPharmacotherapyPharmaceutical Chemistry	1997	64
Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists Thais M. Sielecki, Jie Liu, Shaker A. Mousa, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineMechanism Of ActionPharmacological Agent	2001	60
?v?3, ?v?5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation Martha H. Corjay, Sheila Diamond, Karen Schlingmann, Journal of Cellular Biochemistry SclerostinEngineeringEarly Time PointsRabbit ModelCytoskeleton	1999	47
ANTITHROMBOTIC ACTIONS OF SELECTIVE INHIBITORS OF BLOOD COAGULATION FACTOR Xa IN RAT MODELS OF THROMBOSIS Pancras C. Wong, Earl J. Crain, Oliver Nguan, Thrombosis Research ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletMedicine	1996	41
Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin Robert J. Leipold, Tracy A. Bozarth, Adrienne L. Racanelli, Journal of Biological Chemistry	1995	36
Orally Active Isoxazoline Glycoprotein IIb/IIIa Antagonists with Extended Duration of Action Richard E. Olson, Thais M. Sielecki, John Wityak, Journal of Medicinal Chemistry ThrombopoiesisThrombosisMedicinal ChemistryAntiplatelet EffectProlonged Antiplatelet Profile	1999	35
Recombinant plasminogen activator inhibitor type 1 Thomas M. Reilly, Shaker A. Mousa, Ramnath Seetharam, Blood Coagulation & Fibrinolysis ImmunologyPathologyCytoskeletonPharmacotherapySerine Protease Inhibitors	1994	23
αvβ3, αvβ5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation Martha H. Corjay, Sheila Diamond, Karen Schlingmann, Journal of Cellular Biochemistry SclerostinEarly Time PointsRabbit ModelOsteoporosisCellular Physiology	1999	22
Oral Antiplatelet Efficacy and Specificity of a Novel Nonpeptide Platelet GPIIb/IIIa Receptor Antagonist, DMP 802 Shaker A. Mousa, Richard E. Olson, Jeffrey M. Bozarth, Journal of Cardiovascular Pharmacology ThrombopoiesisThrombosisBlood PlateletOral Antiplatelet EfficacyMedicine	1998	13
Comparison of Recombinant Plasminogen Activator Inhibitor-1 and Epsilon Amino Caproic Acid in a Hemorrhagic Rabbit Model Adrienne L. Racanelli, Mark J Diemer, A Cathy Dobies, Thrombosis and Haemostasis InflammationThrombosisHemorrhagic Rabbit ModelR-tpa-induced HemorrhageMedicine	1992	10

Page 1